Authors
Latest:
Balancing Motherhood and Medicine: Navigating Maternity in OphthalmologyBalancing motherhood & ophthalmology: Prioritize family planning, set boundaries, integrate work & personal life. Insights from ophthalmologist-moms.
Latest:
Novel Intravitreal Injections: Faricimab and Aflibercept 8mg for the Treatment of Retinal DiseasesPanelists discuss how novel intravitreal agents faricimab and high-dose aflibercept 8mg offer potential advantages in treating retinal diseases through their extended durability and dual mechanism of action.
Latest:
Managing neovascular retinal disease in COVID-19 era requires careful approachMinimizing clinic visits, maximizing use of imaging modalities are key.
Latest:
Unlocking health mysteriesResearchers find a strong link between Alzheimer's disease and retinal thinning
Latest:
New and upcoming MIGS with Shan Lin, MDShan Lin, MD, speaks to the new MIGS entering the glaucoma space and providing additional options for patients and providers as they work to preserve vision and work towards a better future for glaucoma treatment options.
Latest:
Updated guidelines enhance choriocapillaris imaging in AMD with SS-OCTACompensation techniques in swept-source optical coherence tomography angiography improve accuracy by correcting signal loss from drusen and other artifacts
Latest:
Enhancing Vision With Small Aperture Extended Depth of Focus IOLs and Adjunctive PRK in Patients With KeratoconusA panelist discusses how a 50-year-old male patient with stabilized keratoconus achieved excellent visual outcomes with an IC-8 small aperture IOL by targeting slight myopia to optimize the defocus curve, followed by adjunctive PRK to address central corneal astigmatism that was causing ghosting despite good uncorrected acuity, emphasizing the critical importance of controlling irregularities in the central 3-mm zone and ensuring nighttime pupil size remains under 5 mm for optimal results.
Latest:
Lessons from the Togo Glaucoma ProjectSLT shows promise as treatment for millions of Africans with glaucoma.
Latest:
ARVO 2025: The first phase 2 study to examine tyrosine kinase inhibitors for wet AMDKatherine Talcott, MD, a retina specialist at Cleveland Clinic, presented findings on EYP-1901 in the phase 2 DAVIO study.
Latest:
Unraveling the genetics of glaucomaDetails enhance knowledge of biological pathways that contribute to disease pathogenesis.
Latest:
Real-world outcomes validate intraocular drug delivery methodOphthalmologists seek methods to control postoperative inflammation.
Latest:
ASRS 2025: Phase 1/2 study update on OCU-410 for geographic atrophyJay Chhablani, MD, presented the phase 1/2 clinical trial data for OCU410, at the 2025 annual meeting of the American Society of Retina Specialists.
Latest:
Envision Summit 2025: Eradicating TRDAt the Envision Summit 2025 in San Juan, Puerto Rico, Kristen Nwanyanwu, MD, MBA, MHS, joined by her children, discussed her talk on eradicating TRD and the family-friendly environment of the conference.
Latest:
Clinical Implications of Port Delivery System in Retinal DiseasesClosing out his discussion on the port delivery system in retinal diseases, Chirag Jhaveri, MD, considers how this approach has impacted the treatment landscape.
Latest:
ZEISS VISULAS Combi availability expands to CanadaZEISS VISULAS Combi is an advanced therapeutic laser workstation offering photodisruption, photocoagulation, and slit lamp technology in a single, comprehensive solution.
Latest:
Celebrating women in leadershipIn ophthalmology, women continue to take on leadership roles and make a difference in the profession.
Latest:
A Cataract Case Study with Dr. Rahul PanditUsing an NSAID to Manage Inflammation and Pain After Cataract Surgery
Latest:
Ophthalmologist Holocaust survivor shares his storyIn observance of International Holocaust Remembrance Day this January 27, John H. Merey, MD, may be the only Holocaust survivor still in the practice of ophthalmology.
Latest:
Promoting Treatment Adherence in nAMD and DMEExperts discuss the use of steroids, particularly in the context of diabetic macular edema (DME). The inflammatory nature of DME reveals the effectiveness of steroids, especially in cases where persistent fluid remains despite anti-VEGF treatment.
Latest:
Q&A: AEVR's executive director on #SeeWhatMatters and safeguarding the National Eye InstituteDan Ignaszewski explains how the national advocacy campaign aims to unite patients, researchers, and clinicians to protect NEI’s independence and ensure vision research funding.
Latest:
Virtual reality brings care to at-need areasTechnology offers accessibility, scalability to countries where care is needed the most.
Latest:
A new era for MacTel: Clinicians react to FDA approval of revakinagene taroretcel-lweyInsights shed light on what the approval means for providers and their patients affected by this neurodegenerative retinal disease
Latest:
Envision Summit 2025: Managing add-ons in a busy retina clinicAt the Envision Summit 2025 in San Juan, Puerto Rico, Ollya Fromal, MD, gave advice on how retina specialists can manage add-ons in their busy retina clinics.
Latest:
Ocular manifestations of mycoplasma-induced rash and mucositisAggressive lubrication combined with topical steroids, antibiotics boosts chances of recovery.
Latest:
Pivotal study data drive glaucoma patient treatment decisionsTwo trials examine factors affecting the risk of disease.
Latest:
Clearing hurdles to large scale telemedicine adoptionDuring the COVID-19 pandemic, it is important to develop technologies to keep patients and staff safe, while treating the diseases of the eye
Latest:
Low-dose atropine causes esotropia in patient caseClinician highlights a novel complication of atropine treatment in a teenage patient.
Latest:
Advancements in ocular drug deliveryOptions empower patients and providers to decrease treatment burden.
Latest:
Focus on molecular mechanisms underlying cataract developmentSeveral hundred genes are associated with congenital forms.
